Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Ghezzi

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Panminerva Medica|October 19, 2020
Biobanking for COVID-19 researchPatrizia Rovere-Querini, Cristina Tresoldi, Caterina Conte, et al.
Cancer Cell|July 11, 2018
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal CancerGiulia Siravegna, Luca Lazzari, Giovanni Crisafulli, et al.
Frontiers in Immunology|August 13, 2024
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVIDMaddalena Noviello, Rebecca De Lorenzo, Raniero Chimienti, et al.
The Lancet. Oncology|November 27, 2025
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trialAlessio Amatu, Giorgio Patelli, Maria Giulia Zampino, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Panminerva Medica|October 19, 2020
Biobanking for COVID-19 researchPatrizia Rovere-Querini, Cristina Tresoldi, Caterina Conte, et al.
Cancer Cell|July 11, 2018
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal CancerGiulia Siravegna, Luca Lazzari, Giovanni Crisafulli, et al.
Frontiers in Immunology|August 13, 2024
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVIDMaddalena Noviello, Rebecca De Lorenzo, Raniero Chimienti, et al.
The Lancet. Oncology|November 27, 2025
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trialAlessio Amatu, Giorgio Patelli, Maria Giulia Zampino, et al.
Pageof 7